Equities research analysts expect Tivity Health, Inc. (NASDAQ:TVTY – Get Rating) to report $0.42 earnings per share for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for Tivity Health’s earnings, with the highest EPS estimate coming in at $0.43 and the lowest estimate coming in at $0.39. Tivity Health reported earnings per share of $0.40 during the same quarter last year, which would indicate a positive year over year growth rate of 5%. The company is expected to issue its next earnings report on Monday, January 1st.
On average, analysts expect that Tivity Health will report full year earnings of $1.80 per share for the current year, with EPS estimates ranging from $1.78 to $1.80. For the next financial year, analysts expect that the business will post earnings of $1.99 per share, with EPS estimates ranging from $1.94 to $2.08. Zacks’ EPS calculations are a mean average based on a survey of sell-side analysts that follow Tivity Health.
Tivity Health (NASDAQ:TVTY – Get Rating) last posted its quarterly earnings data on Thursday, February 24th. The company reported $0.30 EPS for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.08). The business had revenue of $126.80 million during the quarter, compared to the consensus estimate of $126.57 million. Tivity Health had a return on equity of 99.51% and a net margin of 21.80%. The company’s revenue for the quarter was up 26.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.38 earnings per share.
TVTY has been the topic of several recent analyst reports. Zacks Investment Research lowered Tivity Health from a “hold” rating to a “sell” rating in a research note on Tuesday, March 1st. Truist Financial increased their target price on shares of Tivity Health from $28.00 to $30.00 in a research report on Wednesday, January 5th. William Blair restated a “market perform” rating on shares of Tivity Health in a research report on Thursday, February 24th. StockNews.com initiated coverage on shares of Tivity Health in a report on Thursday. They set a “hold” rating for the company. Finally, Credit Suisse Group boosted their target price on Tivity Health from $29.00 to $31.00 and gave the stock a “neutral” rating in a report on Friday, March 11th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $30.67.
A number of hedge funds have recently made changes to their positions in TVTY. Kendall Capital Management grew its position in shares of Tivity Health by 3.0% in the 4th quarter. Kendall Capital Management now owns 15,415 shares of the company’s stock valued at $408,000 after purchasing an additional 445 shares during the period. Mutual of America Capital Management LLC raised its holdings in shares of Tivity Health by 9.3% during the third quarter. Mutual of America Capital Management LLC now owns 5,892 shares of the company’s stock worth $136,000 after acquiring an additional 503 shares during the period. Man Group plc raised its holdings in shares of Tivity Health by 5.1% during the third quarter. Man Group plc now owns 17,212 shares of the company’s stock worth $396,000 after acquiring an additional 838 shares during the period. American Century Companies Inc. raised its holdings in shares of Tivity Health by 2.5% during the third quarter. American Century Companies Inc. now owns 38,367 shares of the company’s stock worth $885,000 after acquiring an additional 919 shares during the period. Finally, National Bank of Canada FI acquired a new stake in shares of Tivity Health during the fourth quarter worth $28,000. 91.07% of the stock is currently owned by hedge funds and other institutional investors.
TVTY traded up $0.08 during midday trading on Thursday, reaching $32.17. 763,212 shares of the company’s stock were exchanged, compared to its average volume of 450,700. The company has a quick ratio of 2.24, a current ratio of 2.24 and a debt-to-equity ratio of 3.23. The business has a 50-day simple moving average of $27.59 and a two-hundred day simple moving average of $25.85. The firm has a market capitalization of $1.60 billion, a price-to-earnings ratio of 15.47, a price-to-earnings-growth ratio of 1.66 and a beta of 2.27. Tivity Health has a one year low of $21.25 and a one year high of $32.75.
Tivity Health Company Profile (Get Rating)
Tivity Health, Inc provides fitness and health products and solutions in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Want More Great Investing Ideas?
Receive News & Ratings for Tivity Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Tivity Health and related companies with MarketBeat.com’s FREE daily email newsletter.